Cart
sales@molnova.com
Hygric acid
CAS No. 475-11-6
Hygric acid( N-Methyl-L-proline )
Catalog No. M28313 CAS No. 475-11-6
Hygric acid (N-Methyl-L-proline) is a proline analogue found in the citrus juices and the juice of bergamot.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 35 | In Stock |
|
| 10MG | 50 | In Stock |
|
| 25MG | 82 | In Stock |
|
| 50MG | 120 | In Stock |
|
| 100MG | 177 | In Stock |
|
| 200MG | 264 | In Stock |
|
| 500MG | 448 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHygric acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionHygric acid (N-Methyl-L-proline) is a proline analogue found in the citrus juices and the juice of bergamot.
-
DescriptionHygric acid (N-Methyl-L-proline) is a proline analogue found in the citrus juices and the juice of bergamot.
-
In Vitro——
-
In Vivo——
-
SynonymsN-Methyl-L-proline
-
PathwayOthers
-
TargetOther Targets
-
RecptorSqualene epoxidase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number475-11-6
-
Formula Weight129.159
-
Molecular FormulaC6H11NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (774.23 mM)
-
SMILESCN1CCC[C@H]1C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sawada M, et al. Synthesis and biological activity of a novel squalene epoxidase inhibitor, FR194738. Bioorg Med Chem Lett. 2004 Feb 9;14(3):633-7.
molnova catalog
related products
-
(R)-HH2853
(R)-HH2853 is a potent EZH2 inhibitor with an IC50 <100 nM for EZH2-Y641F.(R)-HH2853 has anticancer and antitumor activity and can be used in autoimmune diseases.
-
Cephaeline dihydrobr...
Reference standards.
-
PF-04937319
PF-04937319 is an activator of glucokinase (EC50 =154.4 ?μM). PF-04937319 maintains glucose-lowering efficacy while mitigating the risk of hypoglycemia observed with many other glucokinase activators. PF-04937319 can be used in research on the treatment of type 2 diabetes mellitus.
